HPV E6 therapeutic vaccine (University of Arkansas/NCI)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameHPV E6 therapeutic vaccine (University of Arkansas/NCI)
Drug Alias NamePepCan
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHead and Neck NeoplasmsCervical Intraepithelial NeoplasiaWarts +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Arkansas Foundation Realty LlcNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Arkansas
Inactive CompaniesNational Cancer Institute
Active IndicationsHead and Neck NeoplasmsCervical Intraepithelial Neoplasia
Inactive IndicationsWartsPapillomavirus Infections

Other Information

ATC CodeN/A
Related LinksN/A